PS1 -125 Assessment of Function and Quality of Life in a Phase II Multi-Institutional Clinical Trial of Fractionated Simultaneous In-Field Boost Radiotherapy for Patients with 1-2 Brain Metastases. (18th October 2016)
- Record Type:
- Journal Article
- Title:
- PS1 -125 Assessment of Function and Quality of Life in a Phase II Multi-Institutional Clinical Trial of Fractionated Simultaneous In-Field Boost Radiotherapy for Patients with 1-2 Brain Metastases. (18th October 2016)
- Main Title:
- PS1 -125 Assessment of Function and Quality of Life in a Phase II Multi-Institutional Clinical Trial of Fractionated Simultaneous In-Field Boost Radiotherapy for Patients with 1-2 Brain Metastases
- Authors:
- Bauman, G
Yartsev, S
Roberge, D
MacRae, R.
Roa, W
Panet-Raymond, V
Masucci, L
Yaremko, B
D'Souza, D.
Palma, D.
Sexton, T.
Yu, E.
Pantarotto, J.R.
Ahmad, B.
Fisher, B.
Dar, A.R.
Lambert, C.
Pond, G.
Stitt, L.
Tay, K.Y.
Rodrigues, G. - Abstract:
- Abstract : We examined functional outcomes and quality of life of whole brain radiotherapy (WBRT) with integrated fractionated stereotactic radiotherapy boost (FSRT) for brain metastases treatment. Methods Eighty seven people with 1-3 brain metastases were enrolled on this Phase II trial of WBRT (30Gy/10)+simultaneous FSRT, (60Gy/10). Results Mean (Min-Max) baseline KPS, Mini Mental Status Exam (MMSE) and FACT-BR quality of life were 83 (70-100), 28 (21-30) and 143 (98-153). Lower baseline MMSE (but not KPS or FACT-Br) was associated with worse survival after adjusting for age, number of metastases, primary and extra-cranial disease status. Crude rates of deterioration (>10 points decrease from baseline for KPS and FACT-Br, MMSE fall to<27) ranged from 26-38% for KPS, 32-59% for FACT-Br and 0-16%for MMSE depending on the time-point assessed with higher rates generally noted at earlier time points (<6months post-treatment). Using a linear mixed models analysis, significant declines from baseline were noted for KPS and FACT-Br (largest effects at 6 weeks to 3 months) with no significant change in MMSE. Conclusions The effects on function and quality of life of this integrated treatment of WBRT+simultaneous FSRT were similar to other published series combining WBRT+SRS.
- Is Part Of:
- Canadian journal of neurological sciences. Volume 43(2016)Supplement 4
- Journal:
- Canadian journal of neurological sciences
- Issue:
- Volume 43(2016)Supplement 4
- Issue Display:
- Volume 43, Issue 4 (2016)
- Year:
- 2016
- Volume:
- 43
- Issue:
- 4
- Issue Sort Value:
- 2016-0043-0004-0000
- Page Start:
- S8
- Page End:
- S8
- Publication Date:
- 2016-10-18
- Subjects:
- Neurology -- Periodicals
Nervous system -- Surgery -- Periodicals
Electronic journals
616.8 - Journal URLs:
- http://journals.cambridge.org/action/displayJournal?jid=CJN ↗
http://www.cjns.org/home.html ↗
http://cjns.metapress.com/link.asp?id=300307 ↗
http://cjns.metapress.com/openurl.asp?genre=journal&issn=0317-1671 ↗ - DOI:
- 10.1017/cjn.2016.351 ↗
- Languages:
- English
- ISSNs:
- 0317-1671
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library STI - ELD Digital Store
- Ingest File:
- 6706.xml